Ata Gh Biochemical Testing Against

---
name: ata-gh-biochemical-testing-against
description: Recommends against biochemical testing for adult growth hormone deficiency when patients exhibit clear-cut features of GHD alongside three or more documented pituitary hormone deficits. Triggers when evaluating a patient with apparent GHD and multiple hormone deficits such as central hypothyroidism, adrenal insufficiency, and hypogonadism.
---

# Recommend against biochemical testing for growth hormone deficiency in specific cases

## STEP 1 — Gather Information
Document clinical features suggestive of growth hormone deficiency (e.g., increased adiposity, reduced lean mass, poor quality of life, fatigue) and assess for other pituitary hormone deficiencies (central hypothyroidism, adrenal insufficiency, hypogonadism, prolactin deficiency, diabetes insipidus) via history, physical exam, and prior test results.

## STEP 2 — Rule In / Rule Out
Are there clear-cut features of GHD AND at least three other documented pituitary hormone deficits? If yes, proceed to Step 3 (no biochemical testing indicated). If no, consider proceeding to GH stimulation testing per standard evaluation.

## STEP 3 — Classify or Stratify
Classify as "No biochemical testing needed" when clear-cut GHD features coexist with ≥3 other hormone deficits; otherwise classify as "Indeterminate/consider testing" and move to decision step.

## STEP 4 — Decide
If classified as "No biochemical testing needed," withhold GH stimulation testing and rely on clinical diagnosis for GHD management. If classified as "Indeterminate/consider testing," order appropriate GH stimulation test (e.g., insulin tolerance, glucagon, or GHRH-arginine) using BMI-adjusted cutoffs.

## Clinical Guardrails / Mimics / Pitfalls
Do not misattribute non-specific symptoms (e.g., fatigue from depression or sleep apnea) as clear-cut GHD features; ensure deficits are truly documented (not assumed). Avoid testing when clinical picture is unequivocal to prevent unnecessary procedures and costs. Remember that biochemical testing may still be warranted if fewer than three other deficits are present or if GHD features are ambiguous.

## Concrete Clinical Example
A 45-year-old woman with post-surgical central hypothyroidism (on levothyroxine), adrenal insufficiency (on hydrocortisone), and hypogonadism (on estrogen replacement) presents with increased waist circumference, reduced exercise tolerance, and low energy. She has clear-cut GHD features and three other documented hormone deficits; biochemical testing for GHD is not recommended.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118